Literature DB >> 30006197

Metabolic aspects of neuronal degeneration: From a NAD+ point of view.

Yo Sasaki1.   

Abstract

Cellular metabolism maintains the life of cells, allowing energy production required for building cellular constituents and maintaining homeostasis under constantly changing external environments. Neuronal cells maintain their structure and function for the entire life of organisms and the loss of neurons, with limited neurogenesis in adults, directly causes loss of complexity in the neuronal networks. The nervous system organizes the neurons by placing cell bodies containing nuclei of similar types of neurons in discrete regions. Accordingly, axons must travel great distances to connect different types of neurons and peripheral organs. The enormous surface area of neurons makes them high-energy demanding to keep their membrane potential. Distal axon survival is dependent on axonal transport that is another energy demanding process. All of these factors make metabolic stress a potential risk factor for neuronal death and neuronal degeneration often associated with metabolic diseases. This review discusses recent findings on metabolic dysregulations under neuronal degeneration and pathways protecting neurons in these conditions.
Copyright © 2018 Elsevier B.V. and Japan Neuroscience Society. All rights reserved.

Entities:  

Keywords:  Axon; Axon degeneration; Metabolism; Neurodegeneration; Nicotinamide adenine dinucleotide

Mesh:

Substances:

Year:  2018        PMID: 30006197      PMCID: PMC6674977          DOI: 10.1016/j.neures.2018.07.001

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  156 in total

Review 1.  Peroxisome proliferator-activated receptors: nuclear control of metabolism.

Authors:  B Desvergne; W Wahli
Journal:  Endocr Rev       Date:  1999-10       Impact factor: 19.871

2.  Marked loss of myelinated nerve fibers in the human brain with age.

Authors:  Lisbeth Marner; Jens R Nyengaard; Yong Tang; Bente Pakkenberg
Journal:  J Comp Neurol       Date:  2003-07-21       Impact factor: 3.215

3.  The Wlds mutation delays robust loss of motor and sensory axons in a genetic model for myelin-related axonopathy.

Authors:  Mohtashem Samsam; Weiqian Mi; Carsten Wessig; Jürgen Zielasek; Klaus V Toyka; Michael P Coleman; Rudolf Martini
Journal:  J Neurosci       Date:  2003-04-01       Impact factor: 6.167

4.  Alpha-Synuclein is degraded by both autophagy and the proteasome.

Authors:  Julie L Webb; Brinda Ravikumar; Jane Atkins; Jeremy N Skepper; David C Rubinsztein
Journal:  J Biol Chem       Date:  2003-04-28       Impact factor: 5.157

5.  TSC2 mediates cellular energy response to control cell growth and survival.

Authors:  Ken Inoki; Tianqing Zhu; Kun-Liang Guan
Journal:  Cell       Date:  2003-11-26       Impact factor: 41.582

6.  Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration.

Authors:  Toshiyuki Araki; Yo Sasaki; Jeffrey Milbrandt
Journal:  Science       Date:  2004-08-13       Impact factor: 47.728

7.  Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease.

Authors:  Brinda Ravikumar; Coralie Vacher; Zdenek Berger; Janet E Davies; Shouqing Luo; Lourdes G Oroz; Francesco Scaravilli; Douglas F Easton; Rainer Duden; Cahir J O'Kane; David C Rubinsztein
Journal:  Nat Genet       Date:  2004-05-16       Impact factor: 38.330

8.  WldS mice are resistant to paclitaxel (taxol) neuropathy.

Authors:  Min Sheng Wang; Albert A Davis; Deborah G Culver; Jonathan D Glass
Journal:  Ann Neurol       Date:  2002-10       Impact factor: 10.422

9.  Inhibiting axon degeneration and synapse loss attenuates apoptosis and disease progression in a mouse model of motoneuron disease.

Authors:  Anna Ferri; Joshua R Sanes; Michael P Coleman; Jeanette M Cunningham; Ann C Kato
Journal:  Curr Biol       Date:  2003-04-15       Impact factor: 10.834

10.  Kynurenine pathway abnormalities in Parkinson's disease.

Authors:  T Ogawa; W R Matson; M F Beal; R H Myers; E D Bird; P Milbury; S Saso
Journal:  Neurology       Date:  1992-09       Impact factor: 9.910

View more
  13 in total

Review 1.  Role of mitochondria in diabetic peripheral neuropathy: Influencing the NAD+-dependent SIRT1-PGC-1α-TFAM pathway.

Authors:  Krish Chandrasekaran; Muragundla Anjaneyulu; Joungil Choi; Pranith Kumar; Mohammad Salimian; Cheng-Ying Ho; James W Russell
Journal:  Int Rev Neurobiol       Date:  2019-06-08       Impact factor: 3.230

Review 2.  Axon injury signaling and compartmentalized injury response in glaucoma.

Authors:  Stephanie B Syc-Mazurek; Richard T Libby
Journal:  Prog Retin Eye Res       Date:  2019-07-10       Impact factor: 21.198

Review 3.  PGC-1α, Sirtuins and PARPs in Huntington's Disease and Other Neurodegenerative Conditions: NAD+ to Rule Them All.

Authors:  Alejandro Lloret; M Flint Beal
Journal:  Neurochem Res       Date:  2019-05-07       Impact factor: 3.996

Review 4.  Progress on mitochondrial silence information regulator family in epilepsy.

Authors:  Feng Zhu; Yingchun Xiang; Linghui Zeng
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2021-06-25

5.  NAD+ Precursors Repair Mitochondrial Function in Diabetes and Prevent Experimental Diabetic Neuropathy.

Authors:  Krish Chandrasekaran; Neda Najimi; Avinash R Sagi; Sushuma Yarlagadda; Mohammad Salimian; Muhammed Ikbal Arvas; Ahmad F Hedayat; Yanni Kevas; Anand Kadakia; James W Russell
Journal:  Int J Mol Sci       Date:  2022-04-28       Impact factor: 6.208

6.  Overexpression of Sirtuin 1 protein in neurons prevents and reverses experimental diabetic neuropathy.

Authors:  Krish Chandrasekaran; Mohammad Salimian; Sruthi R Konduru; Joungil Choi; Pranith Kumar; Aaron Long; Nina Klimova; Cheng-Ying Ho; Tibor Kristian; James W Russell
Journal:  Brain       Date:  2019-12-01       Impact factor: 13.501

Review 7.  Regulation and metabolic functions of mTORC1 and mTORC2.

Authors:  Angelia Szwed; Eugene Kim; Estela Jacinto
Journal:  Physiol Rev       Date:  2021-02-18       Impact factor: 46.500

Review 8.  Carbohydrate and Amino Acid Metabolism as Hallmarks for Innate Immune Cell Activation and Function.

Authors:  Haoxin Zhao; Lydia N Raines; Stanley Ching-Cheng Huang
Journal:  Cells       Date:  2020-02-27       Impact factor: 6.600

9.  Nicotinamide Mononucleotide Administration Prevents Experimental Diabetes-Induced Cognitive Impairment and Loss of Hippocampal Neurons.

Authors:  Krish Chandrasekaran; Joungil Choi; Muhammed Ikbal Arvas; Mohammad Salimian; Sujal Singh; Su Xu; Rao P Gullapalli; Tibor Kristian; James William Russell
Journal:  Int J Mol Sci       Date:  2020-05-26       Impact factor: 5.923

Review 10.  Targeting the Mitochondrial Pyruvate Carrier for Neuroprotection.

Authors:  Bor Luen Tang
Journal:  Brain Sci       Date:  2019-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.